Literature DB >> 21048427

Epigenetic regulation of immune cell functions during post-septic immunosuppression.

William F Carson1, Karen A Cavassani, Yali Dou, Steven L Kunkel.   

Abstract

Studies in humans and animal models indicate that profound immunosuppression is one of the chronic consequences of severe sepsis. This immune dysfunction encompasses deficiencies in activation of cells in both the myeloid and lymphoid cell lineages. As a result, survivors of severe sepsis are at risk of succumbing to infections perpetrated by opportunistic pathogens that are normally controlled by a fully functioning immune system. Recent studies have indicated that epigenetic mechanisms may be one driving force behind this immunosuppression, through suppression of proinflammatory gene production and subsequent immune cell activation, proliferation and effector function. A better understanding of epigenetics and post-septic immunosuppression can improve our diagnostic tools and may be an important potential source of novel molecular targets for new therapies. This review will discuss important pathways of immune cell activation affected by severe sepsis, and highlight pathways of epigenetic regulation that may be involved in post-septic immunosuppression.

Entities:  

Mesh:

Year:  2011        PMID: 21048427      PMCID: PMC3092675          DOI: 10.4161/epi.6.3.14017

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  105 in total

1.  CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis.

Authors:  Philip O Scumpia; Priscilla F McAuliffe; Kerri A O'Malley; Ricardo Ungaro; Takefumi Uchida; Tadashi Matsumoto; Daniel G Remick; Michael J Clare-Salzler; Lyle L Moldawer; Philip A Efron
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis.

Authors:  Philip O Scumpia; Matthew J Delano; Kindra M Kelly; Kerri A O'Malley; Philip A Efron; Priscilla F McAuliffe; Todd Brusko; Ricardo Ungaro; Tolga Barker; James L Wynn; Mark A Atkinson; Westley H Reeves; Michael J Clare Salzler; Lyle L Moldawer
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 3.  Chemokines provide the sustained inflammatory bridge between innate and acquired immunity.

Authors:  Ana L Coelho; Cory M Hogaboam; Steven L Kunkel
Journal:  Cytokine Growth Factor Rev       Date:  2005-06-20       Impact factor: 7.638

4.  Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile.

Authors:  Haitao Wen; Cory M Hogaboam; Jack Gauldie; Steven L Kunkel
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

5.  Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response.

Authors:  Stefanie B Flohé; Hemant Agrawal; Daniel Schmitz; Michaela Gertz; Sascha Flohé; F Ulrich Schade
Journal:  J Leukoc Biol       Date:  2005-12-19       Impact factor: 4.962

6.  LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression.

Authors:  Hnin Thanda Aung; Kate Schroder; Stewart R Himes; Kristian Brion; Wendy van Zuylen; Angela Trieu; Harukazu Suzuki; Yoshihide Hayashizaki; David A Hume; Matthew J Sweet; Timothy Ravasi
Journal:  FASEB J       Date:  2006-07       Impact factor: 5.191

7.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.

Authors:  Jane C Deng; Genhong Cheng; Michael W Newstead; Xianying Zeng; Koichi Kobayashi; Richard A Flavell; Theodore J Standiford
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

8.  Splenic CD4+ T cells have a distinct transcriptional response six hours after the onset of sepsis.

Authors:  Jonathan E McDunn; Isaiah R Turnbull; Ashoka D Polpitiya; Alice Tong; Sandra K MacMillan; Dale F Osborne; Richard S Hotchkiss; Marco Colonna; J Perren Cobb
Journal:  J Am Coll Surg       Date:  2006-09       Impact factor: 6.113

9.  Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation.

Authors:  M Cristina Lebre; Tim Burwell; Pedro L Vieira; Jose Lora; Anthony J Coyle; Martien L Kapsenberg; Björn E Clausen; Esther C De Jong
Journal:  Immunol Cell Biol       Date:  2005-10       Impact factor: 5.126

10.  Human dendritic cells following Aspergillus fumigatus infection express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 cytokines, which lead to a Th1 response.

Authors:  Valérie Gafa; Roberto Lande; Maria Cristina Gagliardi; Martina Severa; Elena Giacomini; Maria Elena Remoli; Roberto Nisini; Carlo Ramoni; Paolo Di Francesco; Delphine Aldebert; Renée Grillot; Eliana M Coccia
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more
  72 in total

Review 1.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

Review 2.  Therapeutic targeting of trained immunity.

Authors:  Willem J M Mulder; Jordi Ochando; Leo A B Joosten; Zahi A Fayad; Mihai G Netea
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

Review 3.  The initiation of metabolic inflammation in childhood obesity.

Authors:  Kanakadurga Singer; Carey N Lumeng
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

4.  Prediction of multiple infections after severe burn trauma: a prospective cohort study.

Authors:  Shuangchun Yan; Amy Tsurumi; Yok-Ai Que; Colleen M Ryan; Arunava Bandyopadhaya; Alexander A Morgan; Patrick J Flaherty; Ronald G Tompkins; Laurence G Rahme
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

Review 5.  Epigenetics and bacterial infections.

Authors:  Hélène Bierne; Mélanie Hamon; Pascale Cossart
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

6.  Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis.

Authors:  Cheryl B Lin; Christoph P Hornik; Reese Clark; C Michael Cotten; Daniel K Benjamin; Michael Cohen-Wolkoweiz; P Brian Smith; James L Wynn
Journal:  Early Hum Dev       Date:  2012-07-27       Impact factor: 2.079

Review 7.  Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation.

Authors:  Charles E McCall; Mohamed El Gazzar; Tiefu Liu; Vidula Vachharajani; Barbara Yoza
Journal:  J Leukoc Biol       Date:  2011-05-24       Impact factor: 4.962

Review 8.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

9.  Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes.

Authors:  Jessica Quintin; Sadia Saeed; Joost H A Martens; Evangelos J Giamarellos-Bourboulis; Daniela C Ifrim; Colin Logie; Liesbeth Jacobs; Trees Jansen; Bart-Jan Kullberg; Cisca Wijmenga; Leo A B Joosten; Ramnik J Xavier; Jos W M van der Meer; Hendrik G Stunnenberg; Mihai G Netea
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

Review 10.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.